Published Guidance, NICE advice and quality standards
Showing 31 to 33 of 33
Title | Reference number | Published | Last updated |
---|---|---|---|
Bortezomib for induction therapy in multiple myeloma before high-dose chemotherapy and autologous stem cell transplantation | TA311 | ||
Bortezomib and thalidomide for the first‑line treatment of multiple myeloma | TA228 | ||
Bortezomib monotherapy for relapsed multiple myeloma | TA129 |